Linda Krostich Mspa Ccc is categorized under Speech Pathologists in Plainview, NY and active since 2001.
Linda Krostich Mspa Ccc was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Speech Pathologists business, which does work in the B2C market, and is classified as a Speech Pathologists, under code number 621340 by the NAICS.
If you are seeking more information, feel free to contact Linda Krostich at the company’s single location by writing to 100 Manetto Hill Road # 101, Plainview, New York NY 11803 or by phoning (516) 931-6707. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Linda Krostich Mspa Ccc |
Contact Person: | Linda Krostich |
Address: | 100 Manetto Hill Road # 101, Plainview, New York 11803 |
Phone Number: | (516) 931-6707 |
Website Address: | ny-plainview.doctors.at |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Speech Pathologists |
SIC Code: | 8049 |
NAICS Code: | 621340 |
Share This Business: |
Linda Krostich Mspa Ccc was started in 2001 to provide professional Speech Pathologists under the SIC code 8049 and NAICS code 621340. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Linda Krostich for inquiries that concern Linda Krostich Mspa Ccc by calling the company number (516) 931-6707, as your correspondence is most welcome. Additionally, the physical location of the single location of Linda Krostich Mspa Ccc can be found at the coordinates 40.780594,-73.470425 as well as the street address 100 Manetto Hill Road # 101 in Plainview, New York 11803.
For its online presence, you may visit Linda Krostich Mspa Ccc’s website at ny-plainview.doctors.at and engage with its social media outlets through on Twitter and on Facebook.